TP53 and prostate carcinoma: Former studies concerning HI, have served as proof of principle: PC-3 and DU145 cell growth inhibition was induced by HIC were the compound act as a p53 stabilizer in prostate cancer cells, however, the detailed molecular mechanism of HIC in combination with any clinical drugs are yet to be investigated [30].